Ji-Min Li Selected Research

Gefitinib (Iressa)

6/2018

Proteomic investigating the cooperative lethal effect of EGFR and MDM2 inhibitors on ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji-Min Li Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 11/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 11/2019
2	Ischemia 02/2017 - 01/2013
1	Hypogonadism (Hypergonadotropic Hypogonadism) 04/2021
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 04/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 06/2018
1	Mouth Neoplasms (Oral Cancer) 01/2018
1	Lymphatic Metastasis 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Glaucoma 02/2017
1	Myocardial Infarction 04/2016
1	Hemorrhage 04/2016
1	Thrombosis (Thrombus) 04/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2016
1	Corneal Injuries 07/2013
1	Reperfusion Injury 01/2013
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2013
1	Skin Neoplasms (Skin Cancer) 04/2012
1	Leiomyoma (Uterine Fibroids) 04/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2012
2	Hyaluronic Acid (Hyaluronan)IBA 07/2013 - 01/2013
1	Androstenedione (4 Androstene 3,17 dione)IBA 04/2021
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 04/2021
1	nintedanibIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	peptide AIBA 01/2021
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	CytokinesIBA 01/2021
1	EnzymesIBA 01/2021
1	SmokeIBA 01/2021
1	arginine deiminaseIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	indium-bleomycinIBA 12/2019
1	Peptides (Polypeptides)IBA 12/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2019
1	Tumor Suppressor Protein p53IBA 06/2018
1	Gefitinib (Iressa)FDA Link 06/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Galectin 1 (LGALS1)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Clopidogrel (Plavix)FDA Link 04/2016
1	ProteomeIBA 07/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	GelsolinIBA 04/2012
1	Blood Proteins (Serum Proteins)IBA 04/2012
1	Transferrin (beta 2 Transferrin)IBA 04/2012
1	HemopexinIBA 04/2012
1	Leucine (L-Leucine)FDA Link 04/2012
1	Fibrinogen (Factor I)FDA Link 04/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2012
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 04/2012
1	fibrinopeptides gammaIBA 04/2012
1	Vitamin D-Binding ProteinIBA 04/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2011
1	Gemcitabine FDA Link 11/2011
1	NAD (NADH)IBA 08/2007

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 11/2019
2	Therapeutics 06/2018 - 01/2018
1	Ligation 04/2021
1	Precision Medicine 06/2018
1	Stents 04/2016